Skip to main content
Erschienen in: Journal of Neurology 8/2016

26.05.2016 | Original Communication

Expanding the spectrum of PEX10-related peroxisomal biogenesis disorders: slowly progressive recessive ataxia

verfasst von: Mathilde Renaud, Claire Guissart, Martial Mallaret, Sacha Ferdinandusse, David Cheillan, Nathalie Drouot, Jean Muller, Mireille Claustres, Christine Tranchant, Mathieu Anheim, Michel Koenig

Erschienen in: Journal of Neurology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Peroxisomal biogenesis disorders (PBDs) consist of a heterogeneous group of autosomal recessive diseases, in which peroxisome assembly and proliferation are impaired leading to severe multisystem disease and early death. PBDs include Zellweger spectrum disorders (ZSDs) with a relatively mild clinical phenotype caused by PEX1, (MIM# 602136), PEX2 (MIM# 170993), PEX6 (MIM# 601498), PEX10 (MIM# 602859), PEX12 (MIM# 601758), and PEX16 (MIM# 603360) mutations. Three adult patients are reported belonging to a non-consanguineous French family affected with slowly progressive cerebellar ataxia, axonal neuropathy, and pyramidal signs. Mental retardation and diabetes mellitus were optional. The age at onset was in childhood or in adolescence (3–15 years). Brain MRI showed marked cerebellar atrophy. Biochemical blood analyses suggested a mild peroxisomal defect. With whole exome sequencing, two mutations in PEX10 were found in the three patients: c.827G>T (novel) causing the missense change p.Cys276Phe and c.932G>A causing the missense change p.Arg311Gln. The phenotypic spectrum related to PEX10 mutations includes slowly progressive, syndromic recessive ataxia.
Literatur
1.
Zurück zum Zitat Anheim M, Tranchant C, Koenig M (2012) The autosomal recessive cerebellar ataxias. N Engl J Med 366(7):636–646 Anheim M, Tranchant C, Koenig M (2012) The autosomal recessive cerebellar ataxias. N Engl J Med 366(7):636–646
2.
Zurück zum Zitat Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW (2006) Peroxisome biogenesis disorders. Biochim Biophys Acta 1763(12):1733–1748CrossRefPubMed Steinberg SJ, Dodt G, Raymond GV, Braverman NE, Moser AB, Moser HW (2006) Peroxisome biogenesis disorders. Biochim Biophys Acta 1763(12):1733–1748CrossRefPubMed
3.
Zurück zum Zitat Waterham HR, Ebberink MS (2012) Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta 1822(9):1430–1441CrossRefPubMed Waterham HR, Ebberink MS (2012) Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta 1822(9):1430–1441CrossRefPubMed
4.
Zurück zum Zitat Sevin C, Ferdinandusse S, Waterham HR, Wanders RJ, Aubourg P (2011) Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene. Orphanet J Rare Dis. BioMed Central Ltd 6(1):8 Sevin C, Ferdinandusse S, Waterham HR, Wanders RJ, Aubourg P (2011) Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene. Orphanet J Rare Dis. BioMed Central Ltd 6(1):8
5.
Zurück zum Zitat Régal L, Ebberink MS, Goemans N, Wanders RJA, de Meirleir L, Jaeken J et al (2010) Mutations in PEX10 are a cause of autosomal recessive ataxia. Ann Neurol 68(2):259–263PubMed Régal L, Ebberink MS, Goemans N, Wanders RJA, de Meirleir L, Jaeken J et al (2010) Mutations in PEX10 are a cause of autosomal recessive ataxia. Ann Neurol 68(2):259–263PubMed
6.
Zurück zum Zitat Zeharia A, Ebberink MS, Wanders RJA, Waterham HR, Gutman A, Nissenkorn A et al (2007) A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40 °C. J Hum Genet 52(7):599–606CrossRefPubMed Zeharia A, Ebberink MS, Wanders RJA, Waterham HR, Gutman A, Nissenkorn A et al (2007) A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40 °C. J Hum Genet 52(7):599–606CrossRefPubMed
7.
Zurück zum Zitat Guissart C, Drouot N, Oncel I, Leheup B, Gershoni-Barush R, Muller J et al (2015) Genes for spinocerebellar ataxia with blindness and deafness (SCABD/SCAR3, MIM# 271250 and SCABD2). Eur J Hum Genet EJHG. Nature Publishing Group 1–6 Guissart C, Drouot N, Oncel I, Leheup B, Gershoni-Barush R, Muller J et al (2015) Genes for spinocerebellar ataxia with blindness and deafness (SCABD/SCAR3, MIM# 271250 and SCABD2). Eur J Hum Genet EJHG. Nature Publishing Group 1–6
8.
Zurück zum Zitat Anheim M, Fleury M, Monga B, Laugel V, Chaigne D, Rodier G et al (2010) Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics 11(1):1–12CrossRefPubMed Anheim M, Fleury M, Monga B, Laugel V, Chaigne D, Rodier G et al (2010) Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics 11(1):1–12CrossRefPubMed
9.
Zurück zum Zitat Wanders RJ, Wiemer EA, Brul S, Schutgens RB, van den Bosch H, Tager JM (1989) Prenatal diagnosis of Zellweger syndrome by direct visualization of peroxisomes in chorionic villus fibroblasts by immunofluorescence microscopy. J Inherit Metab Dis 12(Suppl 2):301–304PubMed Wanders RJ, Wiemer EA, Brul S, Schutgens RB, van den Bosch H, Tager JM (1989) Prenatal diagnosis of Zellweger syndrome by direct visualization of peroxisomes in chorionic villus fibroblasts by immunofluorescence microscopy. J Inherit Metab Dis 12(Suppl 2):301–304PubMed
10.
Zurück zum Zitat Dacremont G, Vincent G (1995) Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts. J Inherit Metab Dis 18(Suppl 1):84–89CrossRefPubMed Dacremont G, Vincent G (1995) Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts. J Inherit Metab Dis 18(Suppl 1):84–89CrossRefPubMed
11.
Zurück zum Zitat Wanders RJ, Ofman R, Romeijn GJ, Schutgens RB, Mooijer PA, Dekker C et al (1995) Measurement of dihydroxyacetone-phosphate acyltransferase (DHAPAT) in chorionic villous samples, blood cells and cultured cells. J Inherit Metab Dis 18(Suppl 1):90–100CrossRefPubMed Wanders RJ, Ofman R, Romeijn GJ, Schutgens RB, Mooijer PA, Dekker C et al (1995) Measurement of dihydroxyacetone-phosphate acyltransferase (DHAPAT) in chorionic villous samples, blood cells and cultured cells. J Inherit Metab Dis 18(Suppl 1):90–100CrossRefPubMed
12.
Zurück zum Zitat DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C et al (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491–498CrossRefPubMedPubMedCentral DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C et al (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491–498CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Geoffroy V, Pizot C, Redin C, Piton A, Vasli N, Stoetzel C et al (2015) VaRank: a simple and powerful tool for ranking genetic variants. Peer J. 3:e796CrossRefPubMedPubMedCentral Geoffroy V, Pizot C, Redin C, Piton A, Vasli N, Stoetzel C et al (2015) VaRank: a simple and powerful tool for ranking genetic variants. Peer J. 3:e796CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA et al (2010) A map of human genome variation from population-scale sequencing. Nature 467(7319):1061–1073 Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA et al (2010) A map of human genome variation from population-scale sequencing. Nature 467(7319):1061–1073
15.
Zurück zum Zitat Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249CrossRefPubMedPubMedCentral Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073–1081CrossRefPubMed Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073–1081CrossRefPubMed
17.
Zurück zum Zitat Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR et al (2014) Pfam: the protein families database. Nucleic Acids Res 42(Database issue):D222–D230 Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR et al (2014) Pfam: the protein families database. Nucleic Acids Res 42(Database issue):D222–D230
18.
Zurück zum Zitat Okumoto K, Itoh R, Shimozawa N, Suzuki Y, Tamura S, Kondo N et al (1998) Mutations in PEX10 is the cause of Zellweger peroxisome deficiency syndrome of complementation group B. Hum Mol Genet 7(9):1399–1405CrossRefPubMed Okumoto K, Itoh R, Shimozawa N, Suzuki Y, Tamura S, Kondo N et al (1998) Mutations in PEX10 is the cause of Zellweger peroxisome deficiency syndrome of complementation group B. Hum Mol Genet 7(9):1399–1405CrossRefPubMed
19.
Zurück zum Zitat Chang CC, Warren DS, Sacksteder KA, Gould SJ (1999) PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import. J Cell Biol 147(4):761–774 Chang CC, Warren DS, Sacksteder KA, Gould SJ (1999) PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import. J Cell Biol 147(4):761–774
20.
Zurück zum Zitat Ebberink MS, Mooijer PAW, Gootjes J, Koster J, Wanders RJA, Waterham HR (2011) Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder. Hum Mutat 32(1):59–69CrossRefPubMed Ebberink MS, Mooijer PAW, Gootjes J, Koster J, Wanders RJA, Waterham HR (2011) Genetic classification and mutational spectrum of more than 600 patients with a Zellweger syndrome spectrum disorder. Hum Mutat 32(1):59–69CrossRefPubMed
21.
Zurück zum Zitat Shimozawa N, Nagase T, Takemoto Y, Suzuki Y, Kondo N (2003) Genetic heterogeneity in Japanese patients with peroxisome biogenesis disorders and evidence for a founder haplotype for the most common mutation in PEX10 gene. Adv Exp Med Biol 544:71CrossRefPubMed Shimozawa N, Nagase T, Takemoto Y, Suzuki Y, Kondo N (2003) Genetic heterogeneity in Japanese patients with peroxisome biogenesis disorders and evidence for a founder haplotype for the most common mutation in PEX10 gene. Adv Exp Med Biol 544:71CrossRefPubMed
22.
Zurück zum Zitat Warren DS, Wolfe BD, Gould SJ (2000) Phenotype-genotype relationships in PEX10-deficient peroxisome biogenesis disorder patients. Hum Mutat 15(6):509–521CrossRefPubMed Warren DS, Wolfe BD, Gould SJ (2000) Phenotype-genotype relationships in PEX10-deficient peroxisome biogenesis disorder patients. Hum Mutat 15(6):509–521CrossRefPubMed
23.
Zurück zum Zitat Steinberg SJ, Snowden A, Braverman NE, Chen L, Watkins PA, Clayton PT et al (2009) A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts. J Inherit Metab Dis 32(1):109–119CrossRefPubMed Steinberg SJ, Snowden A, Braverman NE, Chen L, Watkins PA, Clayton PT et al (2009) A PEX10 defect in a patient with no detectable defect in peroxisome assembly or metabolism in cultured fibroblasts. J Inherit Metab Dis 32(1):109–119CrossRefPubMed
Metadaten
Titel
Expanding the spectrum of PEX10-related peroxisomal biogenesis disorders: slowly progressive recessive ataxia
verfasst von
Mathilde Renaud
Claire Guissart
Martial Mallaret
Sacha Ferdinandusse
David Cheillan
Nathalie Drouot
Jean Muller
Mireille Claustres
Christine Tranchant
Mathieu Anheim
Michel Koenig
Publikationsdatum
26.05.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 8/2016
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8167-3

Weitere Artikel der Ausgabe 8/2016

Journal of Neurology 8/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.